Rapport Therapeutics (RAPP) Stock Performance Update
Trading Session: 24‑hour period ending at 03:13 AM Central Europe, Thursday 22 April 2026Current Price: USD 25.06 per shareShare Volume: 47.9 million shares outstandingMarket Capitalisation: USD 1.4 billion24‑Hour Trading Volume: USD 240.8 million
Recent Price Movement
- The stock closed 2.69 % higher during the reported period.
- Over the last month, the stock has declined 25.95 %.
Technical Indicators
- 200‑Day Simple Moving Average (SMA): USD 35.76
- 52‑Week High: USD 52.93 (recorded on 27 August 2026)
- 52‑Week Low: USD 23.75 (recorded on 17 November 2025)
Peer Performance (Last 24 Hours)
| Stock | Symbol | Change | Current Price | Market Cap (USD) |
|---|---|---|---|---|
| Alphatec | ATEC | +4.32 % | USD 10.86 | USD 1.6 billion |
| Newcleo | NWCL | –9.89 % | USD 4.21 | USD 1.6 billion |
| Sharplink | SBET | +5.5 % | USD 8.35 | USD 1.6 billion |
| Intellia Therapeutics | NTLA | +2.25 % | USD 11.65 | USD 1.6 billion |
| Omnicell | OMCL | +1.9 % | USD 36.34 | USD 1.6 billion |
Additional Note on Omnicell (OMCL): Price‑to‑earnings ratio is 42.47.
The information presented reflects the latest publicly available trading data for Rapport Therapeutics and its peers as of the specified 24‑hour window.
